“十三五”期间中国肝癌药物临床试验进展
俞悦, 黄慧瑶, 吴大维, 王书航, 于安琪, 樊琦, 白颖, 杜静婷, 方元, 江宁, 房虹, 唐玉, 李宁
Progress on clinical trials of anticancer drug for hepatocellular carcinoma in China during the 13th Five-Year Plan Period
Yu Yue, Huang Huiyao, Wu Dawei, Wang Shuhang, Yu Anqi, Fan Qi, Bai Ying, Du Jingting, Fang Yuan, Jiang Ning, Fang Hong, Tang Yu, Li Ning
肝癌电子杂志
.
2021, (4): 26
-30
.
